Advantages of intraoperative implantation of Impella 5.5 SmartAssist in the Management of Acute Post-Infarction Ventricular Septal Defect with cardiogenic shock

BACKGROUND: Despite advances in surgical techniques and aggressive therapy of post-infarction ventricular septal defect (VSD) with cardiogenic shock, the overall morbidity and mortality is frustratingly high. The Impella 5.5 SmartAssist (Abiomed, Danvers, MA) is a surgically implanted temporary devi...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Cardiothorac Surg
Hlavní autoři: Madjarov, Jeko M., Katz, Michael G., Madzharov, Svetozar, Fazal, Shahood, Robicsek, Francis
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2021
Témata:
Case Report
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8130376/
https://ncbi.nlm.nih.gov/pubmed/34001192
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13019-021-01513-y
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky